Working… Menu
Trial record 1 of 1 for:    APOLLO | APL | Germany
Previous Study | Return to List | Next Study

Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia (TUD-APOLLO-064)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02688140
Recruitment Status : Recruiting
First Posted : February 23, 2016
Last Update Posted : March 3, 2020
Gruppo Italiano Malattie EMatologiche dell'Adulto
Groupe Francophone des Myelodysplasies
HOVON - Dutch Haemato-Oncology Association
Programa para el Tratamiento de Hemopatías Malignas
German Federal Ministry of Education and Research
Teva Pharmaceuticals Europe
Information provided by (Responsible Party):
Technische Universität Dresden

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2021
Estimated Study Completion Date : January 2022